Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy


      Maternal mortality rates rose markedly from 2002 to 2006 in California, prompting an in-depth maternal mortality review in a state that comprises one twelfth of the US birth cohort. Cardiovascular disease has emerged as the leading cause of pregnancy-related death in the United States. The primary aim of this analysis was to describe the incidence and type of cardiovascular disease as a cause of pregnancy-related mortality in California. The secondary aims were to describe racial/ethnic and socioeconomic disparities, risk factors, birth outcomes, timing of death and diagnosis, and signs and symptoms of cardiovascular disease and identify contributing factors.

      Study Design

      The California Pregnancy-Associated Mortality Review retrospectively examined a case series of 64 cardiovascular pregnancy-related deaths from 2002 through 2006. Two cardiologists independently reviewed complete inpatient and outpatient medical records including laboratory, radiology, electrocardiogram, chest X-ray, echocardiograms, and autopsy findings for each cardiovascular death and classified cause of death by type of cardiovascular disease. Demographic data, racial disparities, risk factors, signs and symptoms, timing of diagnosis and death, birth outcomes, and contributing factors were analyzed using bivariate comparisons with noncardiovascular pregnancy-related deaths and population-based data.


      Among 2,741,220 California women who gave birth, 864 died while pregnant or within 1 year of pregnancy; 257 of the deaths were deemed pregnancy related, and of these, 64 (25%) were attributed to cardiovascular disease. There were 42 deaths caused by cardiomyopathy, and the pregnancy-related mortality rate from cardiomyopathy was 1.54 per 100,000 births. Dilated cardiomyopathy existed in 29 cases, of which 15 met the definition of peripartum cardiomyopathy. Women with cardiovascular disease were more likely than women who died from noncardiovascular causes to be African-American (39.1% vs 16.1%; P < .01) and more likely to use illicit substances (23.7% vs 9.4%; P < .01). Thirty-seven percent were obese and 20% had a concomitant diagnosis of hypertension or preeclampsia during pregnancy. Health care decisions in the diagnosis or treatment of cardiovascular disease during and after pregnancy contributed to the fatal outcomes.


      African-American race, substance use, and obesity were risk factors for pregnancy-related cardiovascular disease mortality. Chronic disease prevention and better recognition and response to cardiovascular disease during pregnancy are needed to reduce maternal mortality.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Engin-Ustun Y.
        • Celen S.
        • Ozcan A.
        • et al.
        Maternal mortality from cardiac disease in Turkey: a population-based study.
        J Matern Fetal Neonatal Med. 2012; 25: 2451-2453
        • Haththotuwa H.R.
        • Attygalle D.
        • Jayatilleka A.C.
        • Karunaratna V.
        • Thorne S.A.
        Maternal mortality due to cardiac disease in Sri Lanka.
        Int J Gynaecol Obstet. 2009; 104: 194-198
        • Schoon M.G.
        • Bam R.H.
        • Wolmarans L.
        Cardiac disease during pregnancy—a Free State perspective on maternal morbidity and mortality.
        S Afr Med J. 1997; 87: C19-22
        • Fett J.D.
        Pregnancy-related mortality due to cardiomyopathy: United States, 1991–1997.
        Obstet Gynecol. 2004; 103: 1342
        • Kuklina E.V.
        • Callaghan W.M.
        Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004–2006.
        Obstet Gynecol. 2010; 115: 93-100
        • Sliwa K.
        • Bohm M.
        Incidence and prevalence of pregnancy-related heart disease.
        Cardiovasc Res. 2014; 101: 554-560
      1. Knight M, Kenyon S, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk JJ, eds, on behalf of MBRRACE–UK. Saving lives, improving mothers' care—lessons learned to inform future maternity care from the UK and Ireland: confidential enquiries into maternal deaths and morbidity 2009–2012. Oxford (United Kingdom): National Perinatal Epidemiology Unit, University of Oxford;2014.2

        • Berg C.J.
        • Callaghan W.M.
        • Syverson C.
        • Henderson Z.
        Pregnancy-related mortality in the United States, 1998 to 2005.
        Obstet Gynecol. 2010; 116: 1302-1309
        • Creanga A.A.
        • Berg C.J.
        • Syverson C.
        • Seed K.
        • Bruce F.C.
        • Callaghan W.M.
        Pregnancy-related mortality in the United States, 2006-2010.
        Obstet Gynecol. 2015; 125: 5-12
        • Creanga A.A.
        • Berg C.J.
        • Ko J.Y.
        • et al.
        Maternal mortality and morbidity in the United States: where are we now?.
        J Womens Health (Larchmt). 2014; 23: 3-9
        • Demakis J.G.
        • Rahimtoola S.H.
        • Sutton G.C.
        • et al.
        Natural course of peripartum cardiomyopathy.
        Circulation. 1971; 44: 1053-1061
        • Gunderson E.P.
        • Croen L.A.
        • Chiang V.
        • Yoshida C.K.
        • Walton D.
        • Go A.S.
        Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes.
        Obstet Gynecol. 2011; 118: 583-591
        • Small M.J.
        • James A.H.
        • Kershaw T.
        • Thames B.
        • Gunatilake R.
        • Brown H.
        Near-miss maternal mortality: cardiac dysfunction as the principal cause of obstetric intensive care unit admissions.
        Obstet Gynecol. 2012; 119: 250-255
      2. The California Pregnancy-Associated Mortality Review (CA-PAMR): update from 2002-2004 Maternal Death Reviews. Available at: 2013. Accessed Jan. 10, 2015.

        • Mitchell C.
        • Lawton E.
        • Morton C.
        • McCain C.
        • Holtby S.
        • Main E.
        California pregnancy-associated mortality review: mixed methods approach for improved case identification, cause of death analyses and translation of findings.
        Matern Child Health J. 2014; 18: 518-526
        • Kotelchuck M.
        An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index.
        Am J Public Health. 1994; 84: 1414-1420
        • Kitzman D.W.
        • Scholz D.G.
        • Hagen P.T.
        • Ilstrup D.M.
        • Edwards W.D.
        Age-related changes in normal human hearts during the first 10 decades of life. Part II (maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old.
        Mayo Clin Proc. 1988; 63: 137-146
        • Sliwa K.
        • Hilfiker-Kleiner D.
        • Petrie M.C.
        • et al.
        Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy.
        Eur J Heart Fail. 2010; 12: 767-778
        • Pearson G.D.
        • Veille J.C.
        • Rahimtoola S.
        • et al.
        Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review.
        JAMA. 2000; 283: 1183-1188
        • Steinhaus D.A.
        • Vittinghoff E.
        • Moffatt E.
        • Hart A.P.
        • Ursell P.
        • Tseng Z.H.
        Characteristics of sudden arrhythmic death in a diverse, urban community.
        Am Heart J. 2012; 163: 125-131
        • Whitehead S.J.
        • Berg C.J.
        • Chang J.
        Pregnancy-related mortality due to cardiomyopathy: United States, 1991–1997.
        Obstet Gynecol. 2003; 102: 1326-1331
        • Harper M.A.
        • Meyer R.E.
        • Berg C.J.
        Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality.
        Obstet Gynecol. 2012; 120: 1013-1019
        • Warren T.Y.
        • Wilcox S.
        • Dowda M.
        • Baruth M.
        Independent association of waist circumference with hypertension and diabetes in African American women, South Carolina, 2007–2009.
        Prev Chronic Dis. 2012; 9: E105
        • Harper M.
        • Dugan E.
        • Espeland M.
        • Martinez-Borges A.
        • Mcquellon C.
        Why African-American women are at greater risk for pregnancy-related death.
        Ann Epidemiol. 2007; 17: 180-185
        • Abbas A.E.
        • Lester S.J.
        • Connolly H.
        Pregnancy and the cardiovascular system.
        Int J Cardiol. 2005; 98: 179-189
        • Kuklina E.
        • Callaghan W.
        Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995–2006.
        BJOG. 2011; 118: 345-352